Clinical Trials Logo

Defibrillator clinical trials

View clinical trials related to Defibrillator.

Filter by:
  • None
  • Page 1

NCT ID: NCT06272344 Recruiting - Pacemaker Clinical Trials

Remote Programming of Cardiac Implantable Electronic Devices 2

REACT 2
Start date: April 24, 2023
Phase: N/A
Study type: Interventional

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators need to be regularly and systematically interrogated and reprogrammed to ensure proper functioning. While remote monitoring allows for partial interrogation at a remote location, full CIED check-up and reprogramming is only possible when the patient visits a cardiologist capable of performing device programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. In this study we aim to evaluate our previously validated remote programming solution (REACT study, NCT05366660) in outpatient device clinics which are close to the patient's home but remote from the CIED expert.

NCT ID: NCT02548819 Completed - MRI Clinical Trials

University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices

CDMR
Start date: September 2015
Phase: N/A
Study type: Observational [Patient Registry]

A single-center registry to prospectively evaluate the safety of non-cardiac/non-thoracic magnetic resonance imaging (MRI) in patients with implanted cardiac devices (pacemakers and implantable cardioverter defibrillators).

NCT ID: NCT01829269 Completed - Defibrillator Clinical Trials

French Attitude Registry in Case of ICD Lead Replacement

FRAGILE
Start date: April 2013
Phase:
Study type: Observational [Patient Registry]

The average survival rate of a defibrillation lead is 91 to 99% at 2 years, 85-95% at 5 years and 60-72% at 8 years. We must also manage alerts for defibrillation probes with a higher complication rate than average. We will therefore be increasingly confronted with faulty sensors or at risk to be replaced. There are no standardized approach for replacing defibrillation lead. A record made in the United States showed significant differences according to the teams strategy in case of failure of defibrillation lead in particular with regard to the decision to explant or abandon the probe. The risk of extracting a defibrillation lead are well known with a major complication rate of 1.6 to 1.95%. Regarding the risk of complications related to the abandonment of a probe we have less data. For some there is no risk to abandon a defibrillation lead. But others reported a complication rate of 5.5% related to pacing discontinued. Main objective: Collect the attitude of different centers and different operators when replacing a failed defibrillation lead or "at risk." Explantation or abandonment of the sensor replaced.